Stem Cell Factor-Responsive FC&RI Bearing Human Mast Cell Line LADI Read more about Stem Cell Factor-Responsive FC&RI Bearing Human Mast Cell Line LADI Patent Cooperation TreatyPCT/US03/02790Filed on 2003-01-29
Modifications of HIV ENV, GAG, and POL Enhance Immunogenicity For Genetic Immunization Read more about Modifications of HIV ENV, GAG, and POL Enhance Immunogenicity For Genetic Immunization US Patent 7,470,430Filed on 2003-02-04
Modifications of HIV ENV,GAG, And POL Enchance Immunogenicity Read more about Modifications of HIV ENV,GAG, And POL Enchance Immunogenicity Australia2001284999Filed on 2001-08-14
Modifications of HIV ENV,GAG, And POL Enhance Immunogenicity For Genetic Immunization Read more about Modifications of HIV ENV,GAG, And POL Enhance Immunogenicity For Genetic Immunization Japan2002-536324Filed on 2001-08-14
Modifications of HIV ENV,GAG, And POL Enchance Immunogenicity for Genetic Immunizations Read more about Modifications of HIV ENV,GAG, And POL Enchance Immunogenicity for Genetic Immunizations European Patent01964108.3Filed on 2001-08-14
Modifications of HIV ENV,GAG, And POL Enchance Immunogenicity for Genetic Immunization Read more about Modifications of HIV ENV,GAG, And POL Enchance Immunogenicity for Genetic Immunization Canada2419822Filed on 2001-08-14
INTERFERON ALPHA HYBRIDS Read more about INTERFERON ALPHA HYBRIDS US Patent 7,235,232Filed on 2003-07-08
Recombinant Parainfluenza Virus Vaccines Attenuated by Deletion or Ablation of a Non-Essential Gene Read more about Recombinant Parainfluenza Virus Vaccines Attenuated by Deletion or Ablation of a Non-Essential Gene US Application 10/030,574Filed on 2002-07-12
Construction of West NIle Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused by West Nile Virus Read more about Construction of West NIle Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused by West Nile Virus Patent Cooperation TreatyPCT/US2003/000594Filed on 2003-01-09
INTERLEUKIN-2 STIMULATED T LYMPHOCYTE CELL DEATH FOR THE TREATMENT OF AUTOIMMUNE DISEASES, ALLERGIC DISORDERS, AND GRAFT REJECTION Read more about INTERLEUKIN-2 STIMULATED T LYMPHOCYTE CELL DEATH FOR THE TREATMENT OF AUTOIMMUNE DISEASES, ALLERGIC DISORDERS, AND GRAFT REJECTION European Patent93916463.8Filed on 1993-06-09